跳至主要内容
临床试验/NCT04886024
NCT04886024已完成不适用

The Serum Ages Levels in Patients With Endometriosis

Kanuni Sultan Suleyman Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年12月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
1
主要终点
Serum Advanced Glycation End Products (AGEs) levels in women with endometriosis

研究概览

简要总结

Serum AGES (Advanced Glycation End Products) levels of endometriosis patients are compared with a group of healthy volunteers of the same age.

详细描述

Serum AGES (Advanced Glycation End Products) levels are compared with 45 endometriosis patients and 45 healthy volunteers of the same age. The energy metabolism of the endometriosis group and its possible relationship with the endometriosis stage will be compared since AGES (Advanced Glycation End Products) gives information about the energy metabolism of the people.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • diagnosed with endometriosis (Surgery or ultrasound)
  • Women without endometriosis

排除标准

  • Women without endometriosis women who are only suspected endometriosis

结局指标

主要结局

Serum Advanced Glycation End Products (AGEs) levels in women with endometriosis

时间窗: 8 months

Serum Serum Advanced Glycation End Products (AGEs) levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group

次要结局

  • Comparison of the relationship between serum Serum Advanced Glycation End Products (AGEs) level and endometriosis stage(8 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pınar Yalcin bahat

Principal Investigator

Kanuni Sultan Suleyman Training and Research Hospital

研究点 (1)

Loading locations...

相似试验

Evaluation of Serum Ages Levels in Patients With... | 临床试验